title: Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
authors.forename: Omer
authors.initials: O
authors.lastname: Dizdar
authors.forename: Banu Sarer
authors.initials: BS
authors.lastname: Yürekli
authors.forename: Tugrul
authors.initials: T
authors.lastname: Pürnak
authors.forename: Salih
authors.initials: S
authors.lastname: Aksu
authors.forename: Ibrahim Celalettin
authors.initials: IC
authors.lastname: Haznedaroglu
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine